University of California identifies new EGFR inhibitors for glioblastoma
A University of California patent describes EGFR (HER1; erbB1) inhibitors potentially useful for the treatment of glioblastoma.
A University of California patent describes EGFR (HER1; erbB1) inhibitors potentially useful for the treatment of glioblastoma.